ReNeuron submitted 2 applications to UK regulatory authority to commence multi-site ischemic stroke P2 clinical trial Read more…
ReNeuron notices of exercise of warrants originally issued in 3/09. Read more…
RENE finalized the shareholder approvals necessary to permit the allotment and the issue of the remaining 95,533,498 of the recent placement. Read more…
LSE: RENE.L fund raising completing at £10M
LSE: RENE.L confirmed that the first patient has been treated to evaluate neural stem cell therapy in stroke patients. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.